OncoViews
Uniting oncologists for borderless exchange
Uniting healthcare professionals for
borderless exchange in oncology
CME-certified
All roundtable sessions accredited
LATEST
E-Learnings
Roundtable Sessions
Aug
29
2025
Gastrointestinal
GI Biomarkers
1h 12 min
Jul
10
2025
Hosted On
Targeted Therapies 2025
LUNGSUMMIT.ORG
Jun
25
2025
Hosted On
Immunotherapies in NSCLC
LUNGSUMMIT.ORG
Jun
17
2025
Hosted On
SCLC 2025
LUNGSUMMIT.ORG
Mar
03
2025
Hematology
Myeloproliferative Neoplasms
1 h 35 min
Dec
18
2024
Women's Cancers
Breast Cancer 2024 Review
1 h 32 min
Dec
17
2024
Lung Cancer
Lung Cancer 2024 REVIEW
1 h 43 min
Nov
26
2024
Lung Cancer
EARLY NSCLC
1 h 37 min
Nov
15
2024
Urogenital
Urogenitale Tumore
2 h 19 min
Nov
06
2024
Antibody Drug Conjugates
Antibody Drug Conjugates
1 h 39 min
Articles
Swiss Approval
Sep
18
2025
Antibody Drug Conjugates
Swissmedic Approvals Expand Options for HR+ Metastatic Breast Cancer: Trastuzumab Deruxtecan and Datopotamab Deruxtecan
PEAK Medicals
Apr
25
2025
Antibody Drug Conjugates, Women's Cancers
Antibody-Drug Conjugates in Breast Cancer: Advancing Precision Treatment
Anne Schultheis
Apr
10
2025
Biomarkers, Lung Cancer
Diagnosis of Lung Cancer: Biomarker Testing on the Road to the Future
Terence Friedlander
Mar
27
2025
Antibody Drug Conjugates, Urogenital
Advancing Frontline Treatment: Managing Enfortumab Vedotin and Pembrolizumab Toxicities in Metastatic Urothelial Cancer
Ilaria Colombo
Feb
25
2025
Women's Cancers
Endometrial Cancer: A Revolution That Is Only Just Beginning
Christina Fotopoulou
Feb
12
2025
Women's Cancers
Advanced Ovarian Cancer: In Search of the Ideal Strategy
EMA Approval
Feb
03
2025
Lung Cancer, Women's Cancers
CHMP Recommends Approval of Three Promising Therapies in the EU
Nuria MarÃa Novoa
Jan
29
2025
Lung Cancer
Surgical Treatment of Lung Cancer: Defining Resectability in the Immunotherapy Era
Apostolos Sarivalasis
Jan
22
2025
Women's Cancers
New Perspectives In The Early And Late Stages Of Cervical Cancer
FDA Approval
Jan
20
2025
Women's Cancers